Global Antinuclear Antibody Test Market 2019: Opportunities, Challenges, and Forecast

The research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the ANA testing market, along with revenue estimates & forecasts and market share analysis.

Don’t miss out on business opportunities in Antinuclear Antibody Test Market

The Global Antinuclear Antibody Test Market is expected to reach USD 1,476.1 Million, at a CAGR of 12.4%

The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this market.

This report segments this ANA testing market based on products, diseases, techniques, end users, and regions. In the product's market, the assay kits & reagents segment is expected to account for the largest share. This segment is also expected to grow at the highest CAGR during the forecast period due to the growth in the number of reagent rental agreements and the increasing prevalence of autoimmune diseases worldwide.

Browse and in-depth TOC on “Antinuclear Antibody Test Market”

73 — Tables

102 — Figures

166 — Pages

Based on techniques, the Antinuclear Antibody Test Market is segmented into three broad segment, namely, enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market owing to expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.

The Antinuclear Antibody Test Market’s end-user segments in this market include clinical laboratories, hospitals, POLs, and other end users. The hospitals segment is expected to account for the largest share in 2016, primarily due to the rising healthcare spending which has resulted in a growth in use of ANA testing products in hospitals. Based on region, the global Antinuclear Antibody Test Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising geriatric population and increasing prevalence of autoimmune diseases.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsampleNew.asp?id=218189007

Key players in the Antinuclear Antibody Test Market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).

Needle-Free Injection System Market Professional Survey Report 2019

According to Latest Market research report Published by MarketsandMarkets the “Needle-Free Injection System Market Size, Share, Demand and Growth Analysis, forecast” the Global Market is expected to reach $ 20.17 billion, at a CAGR of 15.5%

Growth in this market is mainly driven by the growing prevalence of the chronic disease, increasing the incidence of communicable disease due to needlestick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

key players operating in the Global Needle-Free Injection System Market;

Companies are focusing on adopting organic as well as inorganic growth strategies such as acquisition, agreements, collaboration, expansion, product upgrades, partnerships, and others (approvals and certifications) to synergistically offer advanced needle-free injection solutions in the market

Key market players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

Major Drivers Impacting the Needle-Free Injection System Market;

· Growing Prevalence of Chronic Diseases

· Increasing Incidence of Communicable Diseases Due to Needlestick Injuries

· Rise in Demand for Self-Injection Devices

· Rising Demand for Biosimilars and Vaccination

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

Global Needle-Free Injection System Market Segmentation:

Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors, and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.

Global Needle-Free Injection System Market, by type of Medication

• Liquid-based needle-free injectors
• Powder-based needle-free injectors
• Projectile/depot-based needle-free injectors

Global Needle-Free Injection System Market, by Application

• Vaccine Needle-free delivery
• Insulin Needle-free delivery
• Pain Management Needle-free delivery
• Oncology Needle-free delivery

Microservices in Healthcare Market Professional Survey Report 2019

The Global Microservices in Healthcare Market is projected to reach USD 343.3 million, at a CAGR of 21.3%

The research report on “Microservices in Healthcare Market by Component (Platform, Services (Consulting, Integration, Training, Support, Maintenance)), Delivery (Cloud, Hybrid, Private, On-premise), End User (Health care Provider, Payer, Life Science) — Global Forecast to 2023”

Download PDF (Delivery — Cloud ):https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119908608

Microservices in Healthcare Market segmentation:

· by Component

· by Delivery Model

· by End-user

· by Region

On the basis of end user, the microservices in healthcare market is segmented into healthcare payers, healthcare providers, life science organizations, and clinical laboratories. The healthcare providers segment is expected to account for the largest share of the overall market in 2018. Government initiatives that help providers gain incentives on the adoption of EHRs and the implementation of integration and connectivity solutions are driving the adoption of microservices architecture solutions among healthcare providers.

The Objectives of this study are as follows:

• To define, describe, and forecast the global microservices in the healthcare market by deployment model, component, end user, and region
• To provide detailed information about the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)

The Major Players Operating in the Microservices in Healthcare Market:

The microservices in healthcare market is marked by the presence of several big and small players. Prominent players in this market include AWS (US), CA Technologies (US), Microsoft (US), Salesforce (US), Pivotal Software (US), Infosys (India), IBM (US), NGINX (US), Oracle Corporation (US), and Syntel (US).

Microsoft is one of the leading providers of microservices. The company caters to the microservices market through the Azure platform. The company’s Service Fabric microservices platform helps enterprises reduce their production time and enable faster application delivery with minimal CAPEX and OPEX. Microsoft focuses on strengthening its R&D efforts to reinvent business productivity, build intelligent cloud platforms, and create personal computing solutions. In June 2018, the company launched Azure Kubernetes Service (AKS) and, in April 2018, the company updated its Service Fabric 6.2. The company also provides its users with economical and convenient products that are integrated with the latest technological solutions and services. Microsoft’s strategy requires it to continuously invest in data centers and other infrastructures to support devices and services.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=119908608

Geographical Detailed Analysis for Microservices in Healthcare Market:

Geographically, the microservices in healthcare market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the market in 2018.

The large share of North America in the global microservices in healthcare market can be attributed to the growing focus on improving the overall efficiency of healthcare organizations and greater product and service availability in the region.

Embolic Protection Devices Market size, Demand, Analysis and Opportunity Forecast

The Growth in this Embolic Protection Devices Market is mainly attributed to factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, the launch of technologically advanced embolic protection devices, and the rising demand for minimally invasive procedures.

The report “Embolic Protection Device Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) — Global Forecast to 2023”

The global market is projected to reach $ 604.9 million by 2023, at a CAGR of 8.3% during the forecast period

By indication, the percutaneous coronary intervention segment accounted for the largest market share in 2017

On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. In 2017, the percutaneous coronary intervention segment accounted for the largest share of the global embolic protection devices market. The large share of this segment can primarily be attributed to the increasing prevalence of CAD and the rising preference for minimally invasive procedures.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158143803

Global Embolic Protection Device Market, By Application

• Cardiovascular Diseases
• Neurovascular Diseases
• Peripheral Diseases

Hospitals are expected to be the largest end users of embolic protection devices during the forecast period

The major end users of embolic protection devices market are hospitals and ambulatory surgical centers. The hospital segment is expected to grow at the highest CAGR during the forecast period. The market for this segment is mainly driven by factors such as the growing number of angioplasty procedures performed in hospitals, rising incidence of chronic vascular diseases, favorable reimbursement scenario in developed countries, growing number of hospitals, and increasing government initiatives to provide quality treatment for cardiovascular diseases.

Geographic Analysis

• Further breakdown of the Rest of Asia Pacific embolic protection devices market into South Korea, Australia, New Zealand, and others
• Further breakdown of the Rest of Europe market into Belgium, Russia, the Netherlands, Switzerland, and others
• Further breakdown of the Rest of Latin America market into Argentina, Colombia, Chile, and others

North America dominated the market. The rising geriatric population and prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding, and the presence of a large number of medical device product manufacturers are driving the growth of the embolic protection device market in North America.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=158143803

The prominent players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).

Thawing System Market Professional Survey Report 2019

The Thawing System Market covers devices that are used to unfreeze and defrost biological samples such as blood and blood products, semen, ovum, embryos, and human tissues.

Factors driving the growth of this market include technologically advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing the use of thawed cells in the treatment of cancers and diabetes.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185341188

Thawing System Market segmentation:

· based on the type

· based on sample type

· based on the end user

· based on regions

The Major Players Operating in the Thawing System Market:

Key players in the thawing system market include Helmer Scientific (US), Boekel Scientific (US), Sarstedt (Germany), Barkey (Germany), BioCision (US), Cardinal Health (US), Sartorius (Germany), GE Healthcare (US), Thermo Fisher Scientific (US), and CytoTherm (US).

The objectives of this study are as follows:

• To define, describe, and forecast the thawing system market on the basis of type, sample type, end user, and region
• To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
• To identify the micro-markets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market
• To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
• To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the thawing system market

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=185341188

Thawing System Market by End User:

• Blood Banks & Transfusion Centers
• Hospitals & Diagnostic Laboratories
• Cord Blood & Stem Cell Banks
• Research & Academic Institutes
• Biotechnology & Pharmaceutical Companies
• Tissue Banks

Geographical Detailed Analysis for Thawing System Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the thawing system market. This is attributed to factors such as improvements in blood bank and biobank infrastructure, increasing research activities in regenerative medicine as well as cell and gene therapy, growing interest in personalized medicine and biomarker discovery, increasing number of biotechnology and pharmaceutical companies, and increasing government funding.

Fractional Flow Reserve Market | Business Overview, Products and Services, Key Insights, Recent Developments

The Fractional Flow Reserve Market growth is largely driven by the increasing geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost-benefits of FFR, and the presence of a favorable reimbursement scenario. Emerging economies are expected to present market players with a wide range of opportunities.

The Fractional Flow Reserve Market is projected to reach USD 1,082 million by 2024 from USD 516 million in 2019, at a CAGR of 16.0% during the forecast period.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=257837023

The invasive monitoring segment accounted for the largest share of the market in 2018

On the basis of technology, the market is segmented into invasive and non-invasive monitoring technologies. In 2018, the invasive monitoring segment accounted for the largest share of the Fractional Flow Reserve Market. The large share of this segment can be attributed to the strong recommendation for FFR usage in coronary angiography.

The pressure guidewires segment is expected to grow at the highest CAGR during the forecast period

On the basis of product, the invasive monitoring market is segmented into pressure guidewires and FFR monitoring systems. The pressure guidewires segment accounted for the largest share of the market in 2018. This can be attributed to the growth in the number of PCI procedures (as a result of the rising prevalence of CVD), strong recommendation for the use of guided revascularization by measuring FFR in specific clinical scenarios, and the single-use nature of pressure guidewires, which ensures repeat purchases.

Recent Developments in Fractional Flow Reserve Market:

• In 2017, Abbott acquired St. Jude Medical, Inc., one of the leading players in cardiovascular and neuromodulation products.
   Abbott Laboratories is a healthcare company that develops, manufactures, and markets a broad and diverse range of health care products. The company operates through four business segments, namely, Established Pharmaceuticals, Diagnostic Products, Nutritional Products, and Cardiovascular and Neuromodulation Products. The company is present in Africa, Asia Pacific, Europe, Latin America, the Middle East, North America, and South America.
• In 2017, HeartFlow, Inc. entered into an agreement with Royal Philips
   Founded in 2007 and headquartered in California (US), HeartFlow is a personalized medical technology company seeking to transform the way cardiovascular disease is diagnosed and treated. The company provides Heartflow FFR-CT, the first available non-invasive solution that enables a physician to more accurately evaluate whether a patient has significant coronary artery disease (CAD) based on both anatomy and physiology. HeartFlow FFRct leverages deep learning to create a personalized 3D model of the patient’s arteries. Through this agreement, Philips will promote the use of the HeartFlow FFRct Analysis in conjunction with Philips’ advanced catheters for the imaging and assessment of a patient’s coronary arteries.

Read a Press Release on “Fractional Flow Reserve Market”:https://www.marketsandmarkets.com/PressReleases/fractional-flow-reserve.asp

Key Questions addressed by the report:

• Which are the key players in the market, and how intense is the competition?
• Emerging countries present immense opportunities for the growth of Fractional Flow Reserve Market. Will this situation persist?
• Which product markets will dominate in the future?
• What are the challenges hindering the adoption of fractional flow reserve solutions?

Additive Manufacturing Market 2019: Global Industry Size, Segments, Share and Growth Factor Analysis Research Report

According to the American Society for Testing and Materials (ASTM), “additive manufacturing” is the “process of joining materials to make objects from 3D model data, usually layer upon layer”. Various synonyms generally used for AM are an additive fabrication, additive processes, additive techniques, additive layer manufacturing, layer manufacturing, and freeform fabrication.

The Additive Manufacturing Market is expected to grow at a CAGR of 13.5% to reach $3,471.9 million

Technological innovations in 3d printing have been witnessed over the past few years. Newer surgical products manufactured from AM, with better safety and efficacy attributes, contribute to the widespread adoption of the additive manufacturing in medical by physicians and patients worldwide.

Download PDF (AM Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=843

Global 3D Printing Market, by industry

• Automotives
• Consumer products
• Business machines
• Medical
• Academic
• Aerospace
• Government/military

Automotive or motor vehicles account for the largest share in this market, primarily due to the easy applications of 3D printing in the production of end-products (engines, spare parts, other interior, and exterior parts) as compared to other segments such as consumer products and business machines, which have limited usage in manufacturing of end-products. Rising healthcare expenditure in emerging economies provides growth opportunities for AM technologies, as new healthcare facilities have come up in these areas.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=843

Geographical Analysis of Additive Manufacturing Market:

Europe accounts for the largest market share of the global additive manufacturing for medical devices market, followed by North America. In the future, it is estimated that the share of the European region will decrease, attributable to lowering device prices, regulatory pressures, and increasing focus of players towards emerging markets in the Asian and Latin American regions.

Major Key Players in Additive Manufacturing Market:

The key players in this market are 3D Systems Corporation (U.S.), 3T RPD (U.K.), Arcam AB (Sweden), Biomedical Modeling, Inc. (U.S.), Envisiontec GmbH (Germany), EOS GmbH Electro Optical Systems (Germany), Fcubic AB (Sweden), GPI Prototype and Manufacturing Services, Inc. (U.S.), Greatbatch, Inc. (U.S.), Layerwise NV (Belgium), Limacorporate SPA (Italy), Materialise NV (Belgium), Medical Modeling, Inc. (U.S.), and others.